en
Scientific article
Review
Open access
French

Les cytokines IL-17, une famille en expansion utilisée comme cible pour des thérapies anti-inflammatoires innovantes

Published inRevue médicale suisse, vol. 16, no. 676-7, p. 28-30
Publication date2020
Abstract

Interleukin 17A is a key effector cytokine in numerous chronic inflammatory diseases. Its neutralization is therapeutically effective and approved in the treatment of chronic inflammatory conditions. Recently, five additional members of the IL-17 cytokine family have been identified, which also contribute to chronic inflammation. Innovative therapeutic strategies therefore aim to simultaneously block not one, but several members of this cytokine family in order to further increase therapeutic efficacy. This article reviews the current knowledge regarding the role of the IL-17 cytokine family in chronic inflammation.

Keywords
  • Anti-Inflammatory Agents
  • Cytokines
  • Humans
  • Inflammation
  • Interleukin-17/physiology
Citation (ISO format)
BOEHNCKE, Wolf-Henning, STALDER MONNEY, Romaine, BREMBILLA, Nicolo Costantino. Les cytokines IL-17, une famille en expansion utilisée comme cible pour des thérapies anti-inflammatoires innovantes. In: Revue médicale suisse, 2020, vol. 16, n° 676-7, p. 28–30.
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1660-9379
137views
56downloads

Technical informations

Creation04/30/2021 4:04:00 PM
First validation04/30/2021 4:04:00 PM
Update time03/16/2023 1:19:27 AM
Status update03/16/2023 1:19:27 AM
Last indexation01/17/2024 2:15:48 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack